The suit escalates a battle between Pfizer and Novo Nordisk over Metsera, whose obesity pipeline could yield new competitors in the weight loss drug market.

Denmark's Novo Nordisk launched a rival bid for U. obesity biotech firm Metsera on Thursday, hijacking an offer from Pfizer ...

New corporate brand reflects strategic transformation to a global biotech platform accelerating access to innovative ...

Something unusual is happening to biotech stocks: They’re going up. A drug-pricing deal between Pfizer and the White House and a spate of deals have sent the SPDR S&P Biotech exchange-traded fund up 9 ...

LONDON, Oct 15 (Reuters) - German biotech firm Tubulis said on Wednesday it had raised 308 million euros ($358 million) in its biggest financing round to date, contributing to a total of 495 million ...

In September 2024, Akeso, a little-known Chinese biopharmaceutical company, announced that clinical trials had shown that its new drug could halt the progression of a type of lung cancer for nearly a ...

After years on the sidelines while investors piled into the next big thing in AI or crypto, biotech is back in focus. The question is whether this rally marks a real recovery or just another ...

Federal funding cuts and threats to higher education are putting key ingredients of Boston’s recipe for biotech success in jeopardy For more than a decade, Boston has been the undisputed capital of ...

Mary Brunkow speaks at an event Tuesday at Seattle’s Institute for Systems Biology celebrating her 2025 Nobel Prize in Physiology or Medicine. (ISB Photo / Alex Garland) The groundbreaking immunology ...

Benzinga’s Edge Stock Rankings system scores stocks across key measures including momentum, growth, value and quality. The momentum score serves as a key indicator for traders looking to capitalize on ...

Nobel Prize winners, from left: Mary Brunkow, senior program manager at the Institute for Systems Biology, Fred Ramsdell, co-founder and chair of Sonoma Biotherapeutic’s scientific advisory board; and ...

A California biotech tycoon has been found guilty of orchestrating a murder-for-hire plot to kill a father of six and former business partner after their oil deal collapsed. Serhat Gumrukcu, 42, of ...